MycoPul® is a multi-component gastrointestinal binder formulation developed by Researched Nutritionals for use under practitioner supervision in clinical protocols requiring comprehensive binding support. Rather than relying on a single-agent approach, MycoPul® combines six distinct binders within its proprietary MycoPlex™ blend, each selected for its affinity for different classes of environmental compounds. This multi-binder strategy reflects the biochemical reality that no single agent provides broad-spectrum binding coverage across chemically diverse substrates.
MycoPlex™ Blend — Ingredient Rationale
Activated Charcoal Activated charcoal is a highly porous, carbonaceous material produced through high-temperature activation of organic precursors. Its exceptionally large surface area facilitates non-specific adsorption of a wide range of lipophilic and hydrophobic compounds in the gastrointestinal lumen, thereby reducing their systemic availability. It is a well-established gastrointestinal adsorbent used in clinical and environmental health contexts.
PureBind™ Humic Acid Humic acid is a complex polyelectrolyte macromolecule derived from the decomposition of organic matter in specific geological deposits. PureBind™ is sourced from a select European peat bog under tightly controlled quality parameters. Humic acids possess a high density of hydroxyl, carboxyl, and phenolic functional groups, conferring affinity for a range of cationic and organic compounds via chelation and adsorption mechanisms within the gastrointestinal environment.
Fulvic Acid Fulvic acid is a low-molecular-weight fraction of humic substances characterised by high water solubility and a dense array of oxygenated functional groups. Due to its smaller molecular size relative to humic acid, fulvic acid exhibits complementary binding characteristics and is capable of interacting with a range of polar and ionic compounds. It supports gastrointestinal binding activity and may contribute to antioxidant mechanisms within the gut lumen.
G-PUR® Purified Zeolite Clinoptilolite Zeolite clinoptilolite is a naturally occurring aluminosilicate mineral with a rigid, three-dimensional cage-like lattice structure that functions via ion exchange and molecular sieving. G-PUR® is a patented, pharmaceutically grade-purified form of clinoptilolite produced by G-Science Inc., employing a proprietary purification process to remove pre-bound environmental contaminants from the raw mineral — thereby maximising available binding sites within the gastrointestinal tract. Clinoptilolite is the preferred clinically utilised zeolite form due to its favourable aluminium-to-silica ratio, structural stability in aqueous environments, and documented affinity for ammonium ions. Unlike some other zeolite variants, clinoptilolite is resistant to degradation in the gastrointestinal tract and does not undergo systemic absorption, supporting its suitability as an inert gastrointestinal adsorbent.
Microchitosan Microchitosan is a partially deacetylated, low-molecular-weight derivative of chitin — a structural polysaccharide found in the exoskeleton of crustaceans. Its cationic character at physiological pH (due to protonation of amino groups) provides strong electrostatic attraction to negatively charged substrates in the gastrointestinal environment. Chitosan derivatives have been investigated for their ability to adsorb a range of compounds in the gut lumen and to support gastrointestinal mucosal integrity.
Allergen Note: Microchitosan is derived from snow crab (crustacean shellfish). Individuals with crustacean shellfish allergy should not use this product.
Silica (from Bamboo Extract) Silica (silicon dioxide) derived from bamboo (Bambusa spp.) extract provides a naturally sourced, food-grade form of this mineral. Silica serves as a supplemental adsorbent in the gastrointestinal lumen, providing additional surface area to the MycoPlex™ binder matrix. Bamboo-derived silica is preferred over synthetic silica forms in premium supplement formulations due to its natural origin and favourable purity profile.
Supplement Facts
|
Per Capsule |
| Serving Size |
1 Capsule |
| Servings Per Container |
30 |
| Ingredient |
Amount Per Serving |
% Daily Value |
| MycoPlex™ Blend |
600 mg |
† |
| — Activated Charcoal |
✦ |
|
| — PureBind™ Humic Acid |
✦ |
|
| — Fulvic Acid |
✦ |
|
| — G-PUR® Purified Zeolite Clinoptilolite |
✦ |
|
| — Microchitosan |
✦ |
|
| — Silica (from Bamboo Extract) |
✦ |
|
† Daily value not established. ✦ Individual component amounts not disclosed by manufacturer; total blend weight 600 mg per capsule.
Other Ingredients: Hypromellose (vegetable capsule).
Directions for Use
Take 1 capsule once daily on an empty stomach — at least 2 hours after eating or 1 hour before eating — or as directed by your healthcare practitioner.
Important: It is recommended to take a broad-spectrum multi-mineral supplement (such as Researched Nutritionals Core Minerals™) at the opposite time of day whilst using MycoPul®, to support mineral balance during use.
Allergen Information
Contains: Crustacean shellfish (Microchitosan — derived from snow crab).
Manufactured without: milk, eggs, fish, tree nuts, peanuts, wheat, soy, corn, or gluten. Produced in a facility that may process ingredients containing these allergens.
Cautions & Contraindications
- Not recommended for use during pregnancy or lactation without prior consultation with a qualified healthcare practitioner.
- Due to the non-specific adsorptive properties of the binder ingredients, MycoPul® has the potential to reduce the gastrointestinal absorption of orally administered pharmaceutical medications, other dietary supplements, and micronutrients. Administer all medications and nutritional supplements at least 2–3 hours separated from MycoPul® dosing.
- Concurrent use of broad-spectrum mineral supplementation is advisable to support mineral balance during sustained use.
- Use with caution in individuals with known crustacean shellfish allergy (see allergen information above).
- Individuals with known gastrointestinal conditions or those on complex medication regimens should seek practitioner guidance before commencing use.